ChinaDaily Briefs

Daily Brief China: Zijin Gold, Baimtec Material , Jinke Smart Services, Iron Ore, BYD, Medcaptain Medical Technology and more

In today’s briefing:

  • Zijin Gold International IPO – Growth Premium at a Mid-Tier Price
  • Quiddity Leaderboard STAR 50/100 Dec25: >US$2bn Combined One-Way Flows; Exp DELs Vs Peers Pair Ideas
  • Jinke Smart (9666 HK): Boyu’s Offer Now Unconditional
  • [IO Technicals 2025/38] Slumping Steel Margins and Rising Stockpiles Weigh on Iron Ore
  • BYD (1211 HK) Tactical Outlook: Rally or Bear Rally?
  • Medcaptain Medical Technology Pre-IPO Tearsheet


Zijin Gold International IPO – Growth Premium at a Mid-Tier Price

By Rahul Jain

  • IPO leaves upside on the table: Priced at HK$71.6/sh (~US$24.1bn EV), Zijin Gold lists at ~8× 2026E EV/EBITDA — in line with peers despite offering far stronger growth.
  • Fastest-Growing gold major challenger: Output set to rise ~20% CAGR to 2027E (2.1Moz), versus flat-to-low growth for Newmont, Barrick, and peers.
  • Fair value HK$95/sh (+33%): Base case target on 2026E EBITDA at 8× peer multiple; risks include gold price volatility, execution of Wassa/Sepon/Raygorodok ramps, and governance overhangs.

Quiddity Leaderboard STAR 50/100 Dec25: >US$2bn Combined One-Way Flows; Exp DELs Vs Peers Pair Ideas

By Janaghan Jeyakumar, CFA

  • STAR 50 Index is a tech-focused, blue-chip index in Mainland China which tracks the top 50 largest and most liquid names in the STAR market of the Shanghai Stock Exchange.
  • STAR 100 index tracks the next 100 names (51st-150th ranks) and it represents the mid-cap segment of the STAR market.
  • In this insight, we take a look at the potential ADDs/DELs for the STAR 50 and STAR 100 indices for the December 2025 index rebal event.

Jinke Smart (9666 HK): Boyu’s Offer Now Unconditional

By David Blennerhassett

  • Back on the 28th April 2025, PRC-incorporated property management play Jinke Smart Services (9666 HK)  announced a possible unconditional MGO take-under at HK$6.67/share. 
  • The Boyu-backed Offeror and Concert Parties holding 37.86% (at the time), bought Jinke Property (000656 CH)‘s 18.05% stake at auction on the 30th March, triggering an unconditional MGO (once completed). 
  • The “Auction Transfer” was subject to CSDC oversight, which has now been satisfied/completed. The Composite Doc is expected to be dispatched on or before the 26th September. 

[IO Technicals 2025/38] Slumping Steel Margins and Rising Stockpiles Weigh on Iron Ore

By Umang Agrawal

  • Iron ore fell as weakening Chinese economic activity, shrinking steel demand, and rising mill maintenance dampened production and demand outlook.
  • Managed Money participants continue to increase their net long exposure, signalling renewed bullish sentiment and expectations of stronger demand and price gains.
  • Bearish MACD crossover and Bollinger Bands pullback signal weakening momentum, highlighting growing selling pressure and short-term downside risk.

BYD (1211 HK) Tactical Outlook: Rally or Bear Rally?

By Nico Rosti

  • In our previous insight from September 2 we suggested if BYD (1211 HK) reached 102 could have been a good BUY signal. 
  • It took a bit more than a couple of week for the stock to bottom at 102.80 (this week), then rally 10%  to 113.50. Impressive, but….
  • … it could be a Bear rally, so in this insight we will try to assess BYD upside potential, and suggest some tactical positioning for the next few weeks.

Medcaptain Medical Technology Pre-IPO Tearsheet

By Hong Jie Seow

  • Medcaptain Medical Technology (MMT) is looking to raise about US$100m in its upcoming Hong Kong IPO. The deal will be run by Morgan Stanley and Huatai International.
  • Medcaptain Medical Technology is a global medical solution provider specializing in life support, minimally invasive intervention, and in vitro diagnostics. 
  • Its products are widely used across hospitals, clinics, testing facilities, and home care scenarios, addressing the needs of critical care, surgery, and diagnostics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars